Bain Capital teams with Pfizer to create new neuroscience-focused company 

When pharma giant Pfizer announced in January it planned to shut down early- and mid-stage neuroscience drug development, it was another blow to a field already in a defensive crouch.

Source link

Leave a Comment

AstraZeneca digs deeper into cancer with Innate stakeLet down by 'agonising' end-of-life care